Strategic objectives

• Synthesize a dendritic system platform capable of acting as a non-viral vector for drug and nucleic acid delivery.
• Synthesize a dendritic system platform with intrinsic therapeutic activity against cancer and microbial diseases, or as an antiviral agent.
• Establish collaborations with other groups within the Institute that may share common research interests.
• Apply for European projects through and with IRYCIS.

Research lines

• Synthesis of carbosilane-type dendritic systems for use as non-viral drug or nucleic acid vectors or as therapeutic agents.
• Dendronization of molecules of pharmacological interest (drugs, peptides, antibodies, etc.).
• Preparation of carbosilane metallodendritic systems for bioinorganic applications.
• Dendronization of nanostructured materials for biomedical applications.
• Synthesis of dendritic nanogels for drug encapsulation.
• Application of dendritic systems against microbial resistance.
• Application of dendritic systems against viruses, particularly HIV.
• Applications of dendritic systems against cancer.
• Applications of dendritic systems against neurodegenerative diseases.